XML 42 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities                    
Net income $ 47,492 $ 4,323 $ 18,290 $ 7,306 $ 30,800 $ 28,600 $ 78,281 $ 46,840 $ (299,500) $ 3,000
Adjustments to reconcile net income to net cash provided by operating activities:                    
Depreciation and amortization             64,652 91,618    
Provision for doubtful accounts and sales returns   800     3,000   3,788 1,721    
Stock-based compensation expense       30,300   55,300 71,079 76,430 105,000  
Deferred taxes       (11,700)   (18,400) (16,682) (21,776) (69,500)  
Amortization of deferred financing costs and discount             1,940 1,786    
Loss on disposition of businesses             0 1,561    
Other non-cash adjustments             (5,180) 2,462    
Changes in operating assets and liabilities, net of acquisition and disposal of businesses:                    
Accounts receivable             (2,422) 918    
Prepaid expenses and other assets   5,200   3,200 9,000 2,500 (9,707) (934) (3,200) 16,700
Trade accounts payable       23,800   19,100 (3,233) 18,322 28,300  
Accrued expenses and other liabilities   (8,100)   8,100 (9,900) (13,400) 2,033 (16,089) (13,000) (29,700)
Deferred revenue   (29,400)   (25,400) 38,800 36,600 22,991 19,527 (1,900) 7,200
Net cash provided by operating activities   1,400   65,300 68,300 118,400 207,540 222,386 296,000 199,600
Cash flows from investing activities                    
Purchase of property and equipment       (1,000)   (6,100) (4,805) (7,235) (7,400)  
Capitalized software development costs             (40,268) (42,882)    
Cash used in disposition of business             (12,235) (1,179)    
Other investing activities             0 (5,029)    
Net cash used in investing activities       (15,200)   (40,700) (57,308) (56,325) (73,400)  
Cash flows from financing activities                    
Proceeds from issuance of debt             307,000 1,303,400    
Payments on debt             (316,922) (1,080,192)    
Debt issuance costs             0 (6,458)    
Employee taxes paid for withheld shares upon equity award settlement             (39,669) (55,950)    
Change in due to customers             (323,467) (263,732)    
Change in customer funds receivable             (1,676) (6,777)    
Purchase of treasury stock, including excise tax payments             (133,338) (325,408)    
Net cash used in financing activities             (508,072) (435,117)    
Effect of exchange rate on cash, cash equivalents and restricted cash             5,768 3,527    
Net decrease in cash, cash equivalents and restricted cash             (352,072) (265,529)    
Cash, cash equivalents and restricted cash, beginning of period   $ 809,512   $ 728,257 $ 809,512 $ 728,257 809,512 728,257 728,257  
Cash, cash equivalents and restricted cash, end of period 457,440   $ 462,728       457,440 $ 462,728 809,512 $ 728,257
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]                    
Cash and cash equivalents 38,255           38,255   67,628  
Total restricted cash 419,185           419,185   741,884  
Total cash, cash equivalents and restricted cash in the statement of cash flows $ 457,440           $ 457,440   $ 809,512